Search Results - "Sangi, Lalram"

Survival outcomes of metaplastic breast carcinoma: An Indian tertiary care center data by Puii, Lalnun, Sarathy, Vinu, Sangi, Lalram, Thomas, Beulah Elsa, Koramati, Samuel Luke, Varayathu, Hrishi, Mufti, Suhail Sayeed, Mathew, Smruthy Ann, Thungappa, Satheesh Chiradoni, Naik, Radheshyam, Ajaikumar, Basavalinga Sadasivaiah

“…Abstract only e12579 Background: Metaplastic breast carcinoma is a rare histological subtype that has basal like characteristics and is reported to have a…”
Get full text

Prognostic subset of metastatic and non-metastatic luminal B breast cancer (LBBC) subtype based on Ki67 index by Puii, Lalnun, Sangi, Lalram, Varayathu, Hrishi, Koramati, Samuel Luke, Thomas, Beulah Elsa, Mathew, Smruthy Ann, Somayaji, Shalaka, Thungappa, Satheesh Chiradoni, Bj, Sriniivas, Munirathnam, Vinayak, Swamy, Shivakumar, BN, Tejaswini, Mufti, Suhail Sayeed, Naik, Radheshyam, Ajaikumar, Basavalinga Sadasivaiah

“…Abstract only e12570 Background: Gene expression profiling for breast cancer has classified ER positive subtype into luminal A and luminal B. Luminal B breast…”
Get full text

Relative dose intensity (RDI) of nab-P in gem+nab-P combination in pancreatic cancer treatment and the prognostic role of baseline NLR by Varayathu, Hrishi, Kurian, Lincil, Murugan, Anju, Mathew, Hephzibah Sara, Rani, Sonia, Thomas, Beulah Elsa, Sangi, Lalram, Somayaji, Shalaka, Mathew, Smruthy Ann, Gupta, Sunny Kumar, Tripathi, Priyank, Mufti, Suhail Sayeed, Naik, Radheshyam, Ajaikumar, Basavalinga Sadasivaiah

“…Abstract only e16269 Background: Combination of Gem+Nab-P is considered as a dose intense regimen which exhibits synergistic cytotoxic activity and equally…”
Get full text

Translational relevance of baseline NLR and LMR ratio in predicting response of EGFR-TKI by Varayathu, Hrishi, Tiwari, Rashi Yogendranath, Somayaji, Shalaka, Mathew, Smruthy Ann, Thomas, Beulah Elsa, Sangi, Lalram, Thomas, Renjan, Balaram, Gautam, Ghosh, Mithua, Thungappa, Satheesh Chiradoni, Mufti, Suhail Sayeed, Bj, Sriniivas, Munirathnam, Vinayak, Naik, Radheshyam, Ajaikumar, Basavalinga Sadasivaiah

“…Abstract only e15020 Background: Neutrophil-Lymphocyte Ratio (NLR) and Lymphocyte-Monocyte Ratio (LMR) have been under scrutiny for their potential as a…”
Get full text

Incidence and severity of systemic allergic reactions (SAR) reported with chemotherapeutic drugs by Thomas, Beulah Elsa, Murugan, Anju, Varayathu, Hrishi, Sangi, Lalram, Rani, Sonia, Somayaji, Shalaka, Mathew, Smruthy Ann, Mathew, Hephzibah Sara, Gupta, Sunny Kumar, Kumar, Dr Goutham, Tripathi, Priyank, Mufti, Suhail Sayeed, Naik, Radheshyam, Ajaikumar, Basavalinga Sadasivaiah

“…Abstract only e18802 Background: SAR, a known adverse event of cancer therapy has variable severity. Despite the availability of many approved grading tools,…”
Get full text

Translational relevance of androgen receptor immunohistochemistry scoring systems for data harmonization in triple negative breast cancer (TNBC) by Mufti, Suhail Sayeed, Lalkota, Bhanu Prakash, BN, Tejaswini, Varayathu, Hrishi, Sarathy, Vinu, Puii, Lalnun, Sangi, Lalram, Thomas, Beulah Elsa, Hazarika, Diganta, Thungappa, Satheesh Chiradoni, Bj, Sriniivas, Patil, Shekar, Naik, Radheshyam, Ajaikumar, Basavalinga Sadasivaiah

“…Abstract only 1078 Background: Androgen receptor (AR) expressing triple negative breast cancer (TNBC) is a sub-set of TNBC with an evolving prognostic and…”
Get full text

Taxane induced pulmonary toxicity in breast cancer by Varayathu, Hrishi, Mathew, Hephzibah Sara, Sarathy, Vinu, Thomas, Beulah Elsa, Kumar, Santosh Elluru, Reddy, Nitheesha, Mufti, Suhail Sayeed, Puii, Lalnun, Sangi, Lalram, Mathew, Smruthy Ann, Koramati, Samuel Luke, S, Dinesh, Swamy, Shivakumar, Naik, Radheshyam, Ajaikumar, Basavalinga Sadasivaiah

“…Abstract only e15522 Background: Taxanes are an integral part of chemotherapy for a broad range of tumor types. The usual toxicities associated with Taxane use…”
Get full text

Translational relevance of baseline peripheral blood biomarkers to assess the efficacy of anti-programmed cell death 1 use in solid malignancies by Varayathu, Hrishi, Sarathy, Vinu, Thomas, Beulah, Mufti, Suhail, Sangi, Lalram, Thungappa, Satheesh, Tripathi, Priyank, Naik, Radheshyam

“…Background: This study is an overall clinical analysis of anti-programmed cell death 1 (PD1) antibodies used in a single institution, emphasizing the role of…”
Get full text